Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma
Patients will be exposed by different specific amplitude-modulated frequencies of low
intensity electromagnetic fields for 30 min. During the exposure, autonomic response with be
recorded in order to identify biofeedback response. Differences in group of frequencies is
expected in patients with hepatitis B carries with or without hepatocellular carcinoma.
Interventional
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Diagnostic
Identification of different group of specific frequencies of modulation in hepatitis B carriers with and without hepatocellular carcinoma associated with biofeedback response
biofeedback response will be monitored
within 10 min of exposure
Yes
Frederico P Costa, MD
Principal Investigator
Hospital Sirio-Libanes
Brazil: National Committee of Ethics in Research
02621512.3.0000.5461
NCT01641276
April 2012
June 2013
Name | Location |
---|